Credence Medsystems Secures $39.9 Million Financing To Enable Scaling Of Innovative Drug Delivery And Connected Health Systems
Credence Medsystems Secures $39.9 Million Financing To Enable Scaling Of Innovative Drug Delivery And Connected Health Systems
09/22/21, 11:07 AM
Location
menlo park
Money raised
$39.9 million
Credence MedSystems, Inc. announced today that it has closed a funding round with gross proceeds of $39.9 million. Sources of funding include strategic investments from Novartis Pharma AG, Molex Ventures LLC as well as additional investors.
Company Info
Location
menlo park, california, united states
Additional Info
Credence MedSystems is an innovator of drug delivery systems that solve unmet market needs for the pharmaceutical industry. Credence’s philosophy of Innovation Without Change allows pharma manufacturers to impress and protect their end users while preserving their existing processes, sourcing strategies and preferred primary package components. The Companion® family of syringe systems includes proprietary needle retraction technology, syringe reuse prevention and other critical safety and usability features. The Dual Chamber Reconstitution platform offers single-step mixing and injection for medicines that require reconstitution at the time of delivery. The Credence Connect™ brings digital connectivity to any syringe. Metered dose systems and other novel devices address the needs of specific therapeutic markets such as ocular therapies and cosmetic applications. Find more information on www.CredenceMed.com.